. The symposium brought together health and environmental scientists to discuss the state of the science and the cross-jurisdictional and methodological challenges in conducting air pollution epidemiology, environmental public health tracking and accountability research. The symposium was held over 2 days and consisted of technical presentations and breakout group discussions on each of the three principal themes of this meeting: (1) monitoring and exposure modeling information, (2) health effects data and (3) linkage of air quality and health data for research, tracking and accountability. This paper summarizes the symposium presentations and the conclusions and recommendations developed during the meeting. The accompanying two papers, which appear in this issue of the Journal, provide more in-depth discussion of issues pertinent to obtaining and analyzing air pollution exposure and health information. The symposium succeeded in identifying areas where there are critical gaps of knowledge in existing air pollution exposure and health information and in discovering institutional or programmatic barriers, which impede accessing and linking disparate data sets. Several suggestions and recommendations emerged from this meeting, directed toward (1) improving the utility of air monitoring data for exposure quantification, (2) improving access to and the quality of health data, (3) studying emerging air quality and health issues, (4) exploring improved or novel methods for linking data and (5) developing partnerships, building capacity and facilitating interdisciplinary communication. The meeting was successful in promoting an interdisciplinary dialogue around these issues and in formulating strategies to support these recommended activities. Finally, this symposium subsequently led to strengthening and initiating new partnerships or interactions between the EPA, CDC, States, academia and the research community at large.
Introduction
The U.S. Environmental Protection Agency (EPA) and the U.S. Centers for Disease Control (CDC) co-organized a symposium on ''Air Pollution Exposure and Health'' at Research Triangle Park, North Carolina on September [19] [20] 2006 . The symposium brought together health and environmental scientists to discuss the state of the science and the crossagencies jurisdictional and methodological challenges in conducting air pollution epidemiology, accountability 2 research and environmental public health tracking. The main goal of this symposium was to facilitate an interdisciplinary dialogue that would identify and prioritize actions to support these activities. At this symposium, air pollution-related exposure and health issues were examined as programs dealing with air pollution are relatively more established than for multimedia pollutants. To this extent, the symposium also provided a forum for interaction between traditional air researchers in toxicology and epidemiology, modelers and those scientists more focused on public health surveillance including the application of indicators that may be used in such surveillance. Adverse effects of air pollution on human health have been well documented. They include acute and chronic effects of particulate matter (PM) and various gaseous air pollutants on morbidity and mortality (Kinney and Ö zkaynak, 1991; Ware et al., 1993; Woodruff et al., 1998; Burnett et al., 2000; Ito et al., 2005; Levy et al., 2005; Dominici et al., 2006; Pope and Dockery, 2006) . Health outcomes associated with air pollution range from changes in respiratory function to exacerbation of symptoms of asthma to more serious cardiopulmonary events, increased hospitalizations and deaths (Schwartz, 1999; Dominici et al., 2006; Gauderman et al., 2007) . As the historic London fog episode of 1952 (U.K. Ministry of Health, 1954; Bell et al., 2004) , public health and academic organizations in the US and abroad began investigating more closely the impact of environmental exposures on human health and disease. Epidemiologic studies (which include longitudinal cohort studies and timeseries studies of air pollution health effects), along with focused panel studies and toxicological evaluations, have established the scientific foundation for development of national and state regulatory standards to protect public health.
As actions are taken to improve air quality and protect public health, there is also a need to evaluate the success of such efforts. Consequently, EPA and other research organizations have begun placing a greater priority on accountability research programs to evaluate the human health impacts of various pollution mitigation or intervention actions. Ultimately, focused examination and assessment of the relationships between emissions, concentrations, exposures and adverse health outcomes will help support the development of more targeted source reduction strategies and improve the ability of EPA to evaluate the public health gains achieved as a result of implementing risk management programs.
The building blocks for understanding the public health impact of air pollution include good health surveillance and environmental monitoring data and appropriate methods and tools that relate these data to human exposures and health risks. In 2002, CDC launched the National Environmental Public Health Tracking Program (Tracking Program) with broad state and local partnerships to integrate environmental, exposure and health information data into a nationwide, standardized, web-based data network (McGeehin et al., 2004) . The Tracking Network is a public health surveillance system that will serve as a ''one-stop shop'' for data and information on environmental exposures, health effects, and, by linking these data, the possible spatial and/or temporal relation between them. These linkages can be used to develop and evaluate policy and interventions to reduce the burden of environmentally related health effects in communities and to generate hypotheses that will stimulate more in-depth research into the air pollution-health relationship. Complementary to CDC's efforts has been the concurrent development in EPA of the Environmental Information Exchange Network (EIEN), which is an Internet-based system used to securely exchange environmental and health data among EPA, states, tribes and territories, and other partners. Considerable effort is underway to allow for smooth data exchange between the Tracking and EIEN networks.
The connections between environmental public health tracking, etiologic research and risk management decisions or health promotion activities are illustrated in Figure 1 . While each component in this diagram uses inputs from a variety of sources, the data and analyses produced in each area can contribute to success in the others. The successes of research, tracking and accountability programs critically depend on our ability to work across disciplines and institutions to (1) reliably estimate pollutant-specific exposures, (2) ascertain cases or health outcomes of concern and (3) link exposures with health effects/diseases by appropriate quantitative techniques or models. Table 1 presents various institutional roles and responsibilities for assessing environmental concentrations, exposure and health data at the local, state and federal level. EPA and CDC are among the key federal organizations involved in addressing the problems of air pollution. However, state, local, academic, private and nonprofit organizations also play a critical role in contributing to information gathering, synthesizing or processing and data analysis activities. It is obvious that the separation of responsibilities regarding environmental, exposure and health Figure 1 . Linkages between environmental public health tracking, etiologic research, risk management decisions and health promotion activities.
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data both at the state and the federal level poses challenges in properly linking these data sets. Furthermore, the freedom to disseminate health data is restricted by state and federal laws designed to protect the privacy of individuals. Yet the success of these programs depends on the development of satisfactory mechanisms to provide researchers with access to health data across multiple state jurisdictions. In addition, differences in the degree of statutory authority directed to environmental and health data reporting, along with limited allocation of resources toward this purpose, have led to variable standardization and completeness of data sets across local and state jurisdictions. The EIEN and the Tracking Program have spurred the development of new and strengthened federal-state partnerships and facilitated progress toward an integrated program linking environmental and health information to support health promotion and risk management initiatives (McGeehin et al., 2004; Litt et al., 2007) . However, this endeavor continues to face significant challenges.
The symposium provided a forum for a systematic evaluation of these issues. The symposium presenters and participants discussed many of the key problems that limit the ability of research, accountability and tracking programs to develop and link environmental, exposure and health measures. Some of the topics discussed include the following: the variability in spatial and temporal coverage of pollutant monitoring data; relevance of ambient monitoring or modeling information for estimating personal exposures; data requirements for empirical as well as physical microenvironmental personal exposure modeling methods; the format, content and validity of vital statistics and medical records; restricted access to health data and compliance with privacy protections; the absence of additional information about individuals that would improve the validity of effect estimates; barriers to the sharing of exposure and health information between institutions and jurisdictions; and the need for complex analytical methodology. Recommendations were developed in issue-specific workgroups to address the limitations and accomplish the stated goals of these programs. The meeting was successful in promoting an interdisciplinary dialogue around these issues and in formulating strategies to support these recommended activities. Finally, this symposium subsequently led to strengthening and initiating new partnerships or interactions between the EPA, CDC, States, academia and the research community at large.
Methods

Organization of the Symposium
The format of the 2-day symposium consisted of introductory keynote presentations followed by moderated presentations on each of the three principal themes of this symposium. These sessions focused on (1) monitoring and exposure modeling, (2) health effects data and (3) linkage of air quality and health data for research, tracking and accountability. After the technical presentations on the second day, the participants were split into four breakout groups, to address the following topics:
ozone, PM and air toxics ambient monitoring and exposure modeling information, health effects data, exposure and health effects data for emerging health and air quality issues, and linkage and analysis of air quality and associated health effects.
The breakout groups also were tasked to identify shortand long-term priorities for future air pollution health effects research, tracking and accountability assessments. After a brief report-out from each of the breakout groups, the symposium participants engaged in a facilitated discussion of priorities, and suggested recommendations for federal and state agencies and health-care providers.
Results
In the following, we summarize the symposium presentations and the conclusions and recommendations developed during the breakout groups and overall group discussions. Complete copies of symposium presentations and the breakout group reports are also available through the symposium website (http://www.epa.gov/nerl/symposium/).
Presentations
Keynote Presentations Dr. Harold Zenick, Director of the National Health and Environmental Effects Research Laboratory (NHEERL) at U.S. EPA's Office and Research and Development (ORD), observed that the motivation for this symposium stemmed from many concurrent activities conducted by CDC and EPA over the last several years. While CDC is moving forward in environmental public health tracking, EPA has produced its first ''Report on the Environment'' (www.epa.gov/roe) and recently ORD launched its accountability research program, which is addressing whether links between agency actions and outcomes can be more directly documented. As part of this recent program, ORD is developing a strategic framework to understand how to link environmental measures and health outcomes and define a research agenda for ORD. Clearly, the EPA's EIEN network and accountability research programs are closely related to CDC's surveillance and tracking activities. For example, EPA scientists are developing exposure models that can be used by CDC epidemiologists in studies of environmentally related health outcomes. In some cases, connections between the efforts of the two agencies are in place, whereas in other cases additional collaborations are being pursued. The hope is that the two agencies can forge a new generation of research that combines both these disciplines in an iterative fashion. Dr. Zenick concluded by stating that relying upon modeling tools may be the most promising way to address many environment-health interactions in the future.
Dr. Michael McGeehin, Director of the Division of Environmental Hazards and Health Effects in CDC's National Center for Environmental Health, discussed the role of surveillance in public health and the need to improve both health and environmental data for public health purposes. Currently, health and environmental data are fragmented and incompatible. To fill data gaps and integrate data systems, CDC's Environmental Public Health Tracking Program is developing a nationwide environmental public health tracking network. Tracking is synonymous with public health surveillance; it involves the ongoing collection, analysis, integration of data and dissemination of information to those who can use it to take action. For tracking, three main types of data are pulled together: hazard, exposure and health effects data. Tracking data will be used to track temporal and spatial trends, identify populations at risk, plan and evaluate public health interventions and stimulate research. To address these functions, the Tracking Program is also building capacity in environmental health at state and local health departments.
Dr. Richard Scheffe, Senior Science Advisor with EPA's Office of Air Quality Planning and Standards (OAQPS), discussed the air accountability and monitoring programs at EPA and the current and emerging air quality management challenges. He discussed the likely implications of the revised PM National Ambient Air Quality Standards on monitoring, exposure, health effects and accountability assessments. As EPA moves to a lower standard for PM, it will be more challenging to monitor environmental conditions for health research and accountability. Within the Multi-Pollutant Analytical Framework of EPA, the agency is evaluating how to harmonize across its current air programs, including criteria air pollutants (CAPs), mercury and hazardous air pollutants (HAPs). The agency is reorganizing its monitoring networks to reflect its multipollutant focus. In addition to its accountability studies, EPA has embraced other issues, such as climate change, the ozone hole and acid rain, in a more comprehensive manner.
Presentations from Session 1: Air Quality Monitoring and Exposure Modeling Information Dr. P. Barry Ryan of Emory University moderated the session, which addressed the current configuration of monitoring networks in the United States and availability of air quality data for modeling human exposure to ambient air pollution. The directive for the four speakers was to evaluate the status of the air monitoring program to recommend future directions.
Tim Hanley, of EPA OAQPS, described the monitoring networks for PM and ozone, which are operated by states, cities and local agencies using grant support from the EPA. EPA supports large robust networks for monitoring 24-h average PM 2.5 , PM 10 and hourly average ozone. These monitors are sited for specific purposes including the ascertainment of high-pollution areas, general population exposure levels and concentrations near specific sources, for example, next to roads. The PM 2.5 measurements are collected at about 600 sites in the United States every third day and at 100 sites every sixth day. The PM 10 measurements are collected either every sixth or third day around 1000 locations in the United States. In contrast, continuous ozone monitors are deployed at approximately 1200 sites by cities and states in areas downwind of cities and operate mostly during the ozone season. There are also 216 chemical speciation sites, where data are collected every third day on PM components including organic carbon, elemental carbon, sulfates, nitrates, carbon monoxide and a host of metals. Speciation is not conducted for near-roadway or sourceoriented monitors. In addition, 35 states collect speciated data on PM 2.5 every sixth day at 110 rural sites in a network called the Interagency Monitoring of Protected Visual Environments, designed to monitor air quality in the nation's national parks. On the other hand, no speciation data are collected for PM 10 , but EPA hopes to improve characterization on coarse PM (PM 10À2.5 ) as part of the planned National Core Monitoring Network by July 2009. EPA is working on improving access to its monitoring data and is organizing a new AirNOW data management center (www.airnowtech.org).
Michael Jones, of EPA OAQPS, described the National Air Toxics Trends Stations (NATTS) monitoring sites, established in [2003] [2004] . The principal objectives of this monitoring program are to address hot spots, environmental justice and public complaint issues. The 23 NATTS (17 urban and 6 rural) are co-located with PM 2.5 speciation samplers. Some sites also are co-located with Photochemical Assessment Monitoring Stations. Samples are analyzed for volatile organic compounds, carbonyls, PM 10 , HAPs, metals and total suspended particulate hexavalent chromium. Additional sites and analyses (e.g., semi-volatile organic compounds) may be added in 2008. Coordination has begun on local exposure and health studies through communityscale monitoring (www.epa.gov/ttn/amtic/aiartoxqa.html).
EPA integrates concentration measurements, emissions information, meteorological and other data in air quality models to predict pollutant concentrations on a national, regional and local geographic scale. Tyler Fox, EPA OAQPS, described the National Air Toxics Assessment (NATA) program, which emphasizes inhalation exposures from facility/pollutant-specific assessments. National-level risk estimates are generated by using census track-level risks by pollutant, generated by dispersion modeling and available emissions. EPA recently released 1999 NATA data. The emerging focus for the NATA program is the integration of HAPs and CAPs through the Community Multiscale Air Quality (CMAQ) modeling framework.
Fred Dimmick, with the National Exposure Research Laboratory (NERL) of EPA ORD, outlined the application of EPA air quality models in a collaborative pilot project called Public Health Surveillance of Air Pollution Related Morbidity and Mortality (PHASE), which involves CDC's Tracking Program, EPA and Tracking Programs in Maine, Wisconsin and New York. The air quality model, CMAQ, is characterized by (1) reliance on complete emission inventories (updated every 3 years) and projections in other years, (2) complex atmospheric chemistry and fine particle chemistry, (3) fusion of CMAQ modeling outputs with monitoring data using statistical hierarchical Bayesian (HB) methods and (4) limitation of model outputs to 2001 and 2002 , with a 2005 model anticipated. CMAQ models air concentrations using square grids that are at 36, 12 km 2 or in some cases even finer spatial resolutions. Comparisons to air quality measurements indicate that, except for modeled organic carbon, the model performs fairly well over space and time. An important issue for air quality model applications in health and accountability studies is the determination of the right resolution needed for matching the model results with different health data. EPA is planning to build a tool for the environmental health tracking program, and will add a data set that can inform concentration-exposure-health linkages. EPA is seeking input concerning the right metadata that health professionals need.
Dr. Lucas Neas (EPA ORD/NHEERL) and Dr. Haluˆk Ö zkaynak (EPA ORD/NERL) discussed alternative approaches to model exposure in air pollution health studies. Different approaches may be appropriate depending on the particular detail and scale of the health data used in an epidemiological study (e.g., county-level daily mortality counts or individual-level health status followed over a period of years). Current approaches range from area-wide assignment of ambient concentration measurements, use of GIS-based modeling methods to more sophisticated physical or mechanistic exposure modeling techniques. Dr. Neas described how GIS-based land use regression (LUR) methods can be used with landscape information (e.g., proximity to roadways, traffic density, distance to nearby pollution sources, etc.) and limited monitoring data to estimate ambient pollutant concentrations at study subjects' geocoded home locations. Dr. Neas presented an example of a study conducted on the exposure of 6000 children in El Paso, Texas, that successfully employed the LUR modeling technique. Applications must address several issues, including how to standardize the traffic metrics across all studies, the applicability of models developed for one location to other geographic areas and whether a comparison can be made with diffusion models. Dr. Ö zkaynak explored how one can go beyond outdoor concentrations to actually predicting personal exposures using physical models. He described the key features of EPA's population exposure models, such as the Stochastic Human Exposure and Dose Simulation (SHEDS) model, Air Pollutant Exposure (APEX) model and the Hazardous Air Pollutant Exposure Model (HAPEM). These models can provide spatially and temporally resolved exposure profiles for representative populations (cf. Burke et al., 2001; Ö zkaynak et al., 2008) , which differ considerably from the corresponding ambient air quality concentrations. Atmospheric fate and transport models coupled with exposure models (i.e., CMAQ with SHEDS, APEX or HAPEM) are now being employed in various epidemiologic and accountability studies at EPA (cf. Isakov et al., 2006; Isakov and Ö zkaynak 2007) .
Presentations from Session 2: Health Effects Data for Air Pollution Research, Tracking, & Accountability Session 2, titled ''Health Effects Data for Air Pollution Research, Surveillance, and Accountability,'' was moderated by Dr. Mark Utell of the University of Rochester. Dr. Utell raised the question, does our health research and surveillance lead to making good decisions? It is important to examine whether regulatory actions to change emission levels result in improved human health. Dr. Utell challenged the session's presenters to consider this research application when addressing sources of data for human health outcomes and links to air pollution.
Tom Sinks, Deputy Director of the National Center for Environmental Health at the CDC, gave an overview of sources of health data available for research and surveillance. Public health promotion depends on surveillance systems. The purpose of surveillance is not regulatory in nature. It provides information to assess public health status, define public health priorities, evaluate programs, develop and target interventions, and disseminate information. Health data include reportable conditions, health-care services data, vital statistics, disease registries (special collections) and surveys including the National Health Interview Survey, National Health and Nutrition Examination Survey and Behavioral Risk Factor Surveillance System. The CDC has identified asthma, chronic obstructive pulmonary disease, cardiovascular disease and mortality to be related to air pollution exposure. Dr. Sinks stressed that information on a smaller geographic scale (county/zip code or smaller) is necessary to track or assess the impact of air pollution on health. Hospital discharge and emergency department visit data, vital statistics, and cancer and birth defects registry data can be obtained from state officials, but researchers must obtain study approval from an institutional review board to gain access to data associated with geographic location. Finally, Dr. Sinks discussed some barriers to gaining access to health data including confidentiality restrictions and data sharing prohibitions imposed by such statutes as the Health Insurance Portability and Accountability Act and Family Educational Rights and Privacy Act developed to assure privacy.
Dr. George Thurston and Dr. Kazuhiko Ito, New York University School of Medicine, discussed the ''State of Science'' for acute health effects research. Dr. Thurston asserted that while there is no doubt that acute exposure to air pollution is associated with excess mortality, the size of the effect is uncertain. Studies examining air pollution effects in multiple cities using a standardized format have been largely consistent, but differences have been reported between studies examining specific particle components. Some sources of uncertainty may include publication bias, adjustments due to weather and methodological issues. Spatial and temporal correlation of PM components has been found to vary across PM species and across cities. There are few monitoring locations collecting daily ambient pollution concentrations and the missing data contribute to a large degree of variability in exposure estimates. Dr. Thurston and Dr. Ito proposed future directions, including resolution of modeling uncertainties (weather effects, lag structure choices), improvement of source-specific effect estimates (expand daily speciation data) and improvement of epidemiologic population exposure estimates (time-activity, outdoorindoor contributions).
The ''State of the Science'' for air pollution-related chronic health effects research was reviewed by Dr. Arden Pope of Brigham Young University. Most air pollution studies have focused on fine particles and the sulfate mortality effect. The literature reporting associations of long-term PM exposure with cardiopulmonary and vascular mortality has grown. Some studies have evaluated respiratory disease and lung function change, heart disease and atherosclerosis, and inflammation/oxidative stress. The relevant timescale for exposure is a key question for research. Risk estimates increase when progressively longer timescales are evaluated ranging from days, to months, to years. The size of the predicted risk also depends on the precision of the exposure estimate. There are research opportunities using existing cohorts to improve concentration and exposure metric assignments and he cited the American Cancer Society and Harvard study cohorts.
Dr. Marni Bekkedal, Wisconsin Department of Health and Family Services, discussed emerging issues in health effects and air pollution. Dr. Bekkedal noted that there is limited documented evidence that neurological diseases such as multiple sclerosis, amyotrophic lateral sclerosis and autism are related to air pollution. She emphasized the need for improvements in case ascertainment, improvements in exposure assignments and the development of evidence of biological plausibility. Currently, these diseases do not have clear and consistent diagnosis criteria as those for some other outcomes such as cancer. Case ascertainment for surveillance purposes, and subsequent linkage with environmental hazards, will be enhanced as standardized diagnosis criteria are established and regularly implemented. In many cases, the relevant period of exposure before disease incidence is believed to range from a few to many years, depending on the disease. This complicates the ability to link outcome with environmental exposures, and highlights the need for consistent, good-quality long-term environmental monitoring and health surveillance. Furthermore, standardized laboratory animal models that could be used to help establish biological plausibility for linkages between these health outcomes and environmental factors are also lacking. Development of toxicological assays to establish links with air pollution exposure will be important to guide surveillance and accountability studies. Dr. Carol Gotway Crawford from CDC provided an overview of methodological and inferential considerations of the analysis of health and environmental data. These data are collected for different purposes, are rarely recorded at the same time and place, and are aggregated at different spatial units. Linking health and environmental data involves harmonizing geographic and temporal units, evaluating spatial support and uncertainty. The statistical analyses must account for the uncertainties that arise from prediction during linkage as well as any uncertainties in the initial data. Linking, analyzing and assessing the uncertainty are often performed as three separate steps, but methods such as Bayesian Hierarchical Models with Kalman Filtering can theoretically perform all three steps simultaneously. Although methods may be developed to compensate for statistical and inferential issues, consideration must always be given to the fact that these data are collected for different purposes.
Dr. Andrew Smith from the Maine Centers for Disease Control and Prevention discussed the states' involvement in the PHASE project. PHASE was designed to enable health departments to link and analyze data on asthma-related emergency department visits and hospitalizations with ozone data. Analysis of asthma and ozone in Maine is hindered by both small numbers of health events and limited ozone monitoring. PHASE provided the means to extend the population under study to three states and to develop new techniques. Ozone monitoring data were combined with modeling data. HB models and case crossover methods were used to evaluate the contribution of ozone to asthma morbidity. Important uncertainties in both the environmental and health data remain and will need to be addressed.
Dr. Eric Roberts of the California Department of Health Services discussed the spatial linkage and analysis of health outcome point data and environmental data. He used the linkage of traffic counts to birth outcome and asthma data in Alameda County to illustrate the benefits and challenges associated with such linkages. For the Alameda County linkage project, available traffic count data were used to create multiple metrics of traffic exposure. Although these metrics were validated using NO 2 measurements taken throughout the county, further refinement is possible if data are available for factors such as the vehicular composition of traffic, temporal variations in traffic counts and personal activity patterns. In addition to validation and improvements in hazard and exposure metrics, further development of spatial analytic methods designed for point data is needed. This linkage project used locally weighted estimation (loess) to account for spatial structure of residuals in the regression model.
Dr. Jerald Fagliano (New Jersey Department of Health and Senior Services) discussed the results and observations of an ecological analysis, linking incident cancers and air toxics at the census tract level. Data for cases of leukemia, brain cancer and angiosarcoma occurring between 1979 and 2002 were obtained from the New Jersey State Cancer Registry. Air toxics exposures were estimated for census tracts using data from the NATA, a national-scale, multi-source model of estimated concentrations of 32 air toxics by EPA. Poisson regression models, adjusted for age, race and poverty level, were generated for leukemia and benzene, brain cancer and vinyl chloride, and angiosarcoma and vinyl chloride. Such ecological analyses present many epidemiologic challenges. In addition to confounding due to unaccounted risk factors and exposure misclassification, these analyses were limited by possible selection bias due to incomplete geocoding. Cancer cases occurring in rural areas were more likely to be dropped from the analysis. Incompleteness in geocoding is a potential problem for ecologic analyses if lost cases are associated with exposure.
A presentation on EPA's accountability program prepared by Dr. Danelle Lobdell (ORD) and Susan Stone (OAQPS) was provided by Dr. Danelle Lobdell. The Clean Air Advisory Committee recommended that EPA work with health effects experts to develop measures to define and assess the human health impacts of air pollution and evaluate progress in reducing those impacts. Traditional evaluation of regulatory decisions and actions involves process indicators such as decreases in emissions, discharges and pollutant levels in environmental media. EPA is currently developing and validating environmental public health indicators. There are several accountability activities within EPA including the OAR/ORD Air Accountability Team, OAQPS Health Indicators, ORD Accountability Initiative and ORD/OEI Report on the Environment. Accountability requires a crossdisciplinary approach and collaboration with multiple stakeholders.
Findings and Recommendations
The meeting participants were next divided into four working groups to address issues related to environmental or health information or establishing linkages between them. The groups were moderated by participants with specific expertise who were tasked to determine short-term and long-term goals to overcome limitations, barriers and challenges associated with relevant (e.g., monitoring, exposure, health or methodological) information applicable for each breakout group. They developed specific recommendations regarding the types of exposure and health information needed, and the methodologies necessary to link them, and suggested approaches to promote better informational exchange between the practitioners of air pollution epidemiology research, tracking and accountability analyses. These findings were then discussed in the final facilitated large-group discussions facilitated by Nancy Tosta (Ross Associates) to identify commonalities and other cross-cutting issues. However, within the time and logistical constraints of this symposium, it was not possible to prioritize these recommendations. Overall, several common themes and recommendations emerged that apply to the entire main symposium themes (i.e., air pollution epidemiology, tracking and accountability). The recommendations are grouped and summarized under the following five categories. A number of these issues are further expanded in the accompanying symposium papers by Thurston et al. (2008) and McKone et al. (2008) .
Improve the Utility of Air Monitoring Data for Exposure Quantification Conference participants strongly endorsed the need to develop better approaches to measure or predict environmental concentrations and personal exposures to air pollutants. Recommendations were formulated for specific pollutants, reflecting the current regulatory orientation for air quality management.
Overall
Evaluate monitoring plans from the point of view of their use for public health and purposes other than regulatory. The enhancements to current monitoring designs should include considerations of appropriate spatial and temporal coverage, to address specific tracking and research needs (e.g., continuous, personal, etc.). The air pollution health community should be provided opportunities to comment before monitor locations are changed or abandoned by the agencies in charge of such monitoring. Support ongoing research to integrate information from human exposure models, such as the SHEDS, APEX, HAPEM models, with ambient concentration measurements in studies of air pollution health effects.
Ozone
Increase the spatial and temporal coverage of ozone monitors to collect more information in rural areas and for time periods characteristic of high and low ambient concentrations. In some areas, information is collected throughout the year (e.g., in California), whereas in other areas these data are collected only during parts of the year, usually the summer months. In some areas (e.g., rural and some urban locations), enhanced spatial coverage and optimum siting of monitors for tracking, health and accountability purposes is recommended. Encourage collection of personal ozone measurements that complement the ambient monitoring data.
PM
Recognize tiered spatial approaches in the design of PM networks to better understand the conditions across different characteristic exposure scales. For health research, it is important to distinguish between localized exposures (e.g., near roadways or near sources); however, it is also important to understand ambient concentrations on neighborhood, urban and even at continental scale. For intermittent exposure events requiring short-term monitoring (e.g., forests fires), rapid deployment of monitors in mobile systems is recommended. Carefully evaluate PM monitoring locations for detailed speciation to support epidemiology, tracking and accountability F based on trends analyses. Further studies for identifying differences in PM levels and composition (e.g., in coastal/inland, near road/away from road) are recommended. It was suggested that EPA and States consider increasing the number of continuous monitoring sites and initiate routine ultrafine monitoring at selected locations. PAHs also need to be ''part of the speciation equation,'' and it is important to investigate not only speciation, but also what is on particles, what is not on particles, as well as gas-particle partitioning.
Air toxics
Federal, state and local agencies should consider expanding the co-location of air toxic monitors with PM mass and speciation monitors, especially in areas identified for health effects research studies.
Improve Access to and the Quality of Health Data Availability and access to health data at various geographic scales were identified as important issues. Possible approaches or mechanisms were proposed. Some approaches can be accomplished in the near-term whereas others will have a longer term horizon.
Standardization of data collection, compilation, and sharing
Work with CDC and state agencies to build relationships and influence data collection, standardization and centralization. State agencies receive death and birth certificates, and hospital discharge data from individual health providers and there are often delays in reporting. In addition, the information reported by hospitals is not standardized, is not always complete, contains limited individual-specific information (e.g., demographic information, behavioral and medical history, time-activity and residential history) and lacks spatial resolution. Additional data are needed about individuals to improve internal and external validity of studies and allow analysts to control for confounding. Work with insurance companies and health-care providers to make available records pertaining to multiple outcomes. New potential data sources are Medicare, local urgent care centers and family physician practice records. Insurance company records may be easily available if researchers identify a collaborator within the institution. Provide capacity within states to improve both access to and quality of health data. State agencies could provide tools and capacity building resources to local health providers to facilitate standardized data collection and reporting. Federal legislation imposing reporting requirements for research and public health practice may be necessary to address these challenges. Develop minimum national standards for health and exposure data collection. Make government reimbursement of care contingent on reporting and participating in data development.
Access to data
State agencies could collaborate to standardize their interpretation of privacy regulations. Policies designed to protect the privacy of information about individuals pose a significant barrier to data access by health researchers and practitioners. For example, data on school absences and the development of childhood asthma symptoms related to air pollution are of interest for accountability and tracking. However, these data are often not collected by schools, and federal laws do not allow their release for research or public health practice when they are.
J Federal agencies could request that the National Academy of Sciences form a blue ribbon panel to identify and address data access issues.
J CDC and EPA should partner in the formulation of guidelines for data access by the environmental health community (e.g., Council of State and Territorial Epidemiologists' guidelines).
Study Emerging Air Quality and Health Issues
The symposium participants recognized the critical need for investigating a wide variety of emerging air quality and health issues. However, to identify health outcomes or conditions of concern, it is necessary to examine and prioritize the available data. Perinatal outcomes, including birth defects, low birth weight, preterm birth and postneonatal mortality, are health effects with emerging evidence of a possible link with air pollution. Other health outcomes requiring more research to better understand their relationship with indoor and outdoor air quality include neurodevelopmental outcomes, autoimmune diseases, childhood ear infections and allergies. For each of these outcomes, important decisions need to be made concerning case ascertainment, exposure assignment and biological plausibility.
Research should initially focus on a narrowed scope of environmental hazards and health outcomes, specifically focusing on those susceptible populations and health outcomes with short latency periods. New guidelines being developed by EPA are focusing on how to do air toxics assessment at the community level. Some areas of concern include the deposition and fate/ transport of persistent bioaccumulative toxics (e.g., mercury emissions from coal-fired power plants) and community-level emissions from autobody shops. As a number of emerging health conditions of interest (e.g., MS, autism, cancers) have long latency periods, it may be useful to collect long-term air pollution deposition monitoring data for some of the multimedia air toxic pollutants. Support the development of additional information to relate personal exposures to ambient monitoring data for many of the air toxics of concern. Identify and validate predictive intermediate biomarkers of effect. Improve and support registries where they exist and initiate them where they do not. As both the databases and methods used to link them are still in early stages, it is important to develop mechanisms to share methods, recommended best practices and metadata between data gatherers and their users.
Explore Improved or Novel Methods for Linking Data Symposium participants recognized that there might be differences in the types of health data and environmental exposure data needed, depending on the research question. Both temporal and spatial incongruities exist between health and environmental data, and quality of these data can vary over time and space as well. These present a significant challenge in integrating these data and drawing conclusions about the health-environment relationships. The participants acknowledged the importance of developing a better understanding of how to conduct spatial and temporal linkages among the data sets with sufficient certainty. 
Conclusions
The symposium succeeded in identifying areas where there are critical gaps of knowledge in existing air pollution exposure and health information and in discovering institutional or programmatic barriers, which impede accessing and linking disparate data sets. Various strategies for enhancing the existing monitoring networks, to meet the specialized needs of human exposure and health researchers, were proposed. Limitations of available monitoring and health data collection systems, and the means to be able to link them, to address emerging air quality and health issues (such as long latency health outcomes, MS, autism, cancers) were addressed. A number of improved or novel approaches for linking environmental, exposure and health data were suggested. Perhaps the most significant problem raised during the meeting was the clear need to improve access to and the quality of existing health data. A number of considerations for standardization of health data collection, compilation and sharing were proposed, and some are now being considered. Participants acknowledged that no single institution can provide all of the expertise nor the resources required to generate the information or the analyses needed to link the various hazard, exposure and health data sets. The symposium participants also recognized that to improve our current capabilities in the area of air pollution and health evaluations, we will need to develop new or stronger collaborations, leverage resources, build capacity and facilitate interdisciplinary communications through future meetings similar to this one. The symposium has already helped catalyze a number of partnerships or interactions between the EPA, CDC, States and the academia. EPA and CDC have recently extended their memorandum of understanding and instituted an interagency agreement focusing further on the EPA-CDC PHASE program. Both EPA and CDC have new and ongoing collaboration with various states that focus on developing and linking enhanced air pollution exposure indicators with available health information. Both agencies are also pursuing new opportunities for establishing expanded collaborations with academia and research community. Finally, EPA and CDC are actively engaged in promoting and facilitating an interdisciplinary dialogue with the exposure and health community through upcoming workshops and conferences. We hope to evaluate the successes and results of these efforts at a follow-up symposium or a suitable meeting in the near future.
